Founded by Prof. Kristian Thygesen, and now chaired by Prof. Bertil Lindhal, this group of experts is focusing on the proper clinical application of cardiac biomarkers including troponins, natriuretic peptides, and inflammatory and thrombotic markers in acute cardiac care.
Interested in advancing the biomarkers science? Apply to be part of the group.
Deadline 20 May 2018
Bertil Lindhal (SW)Chair
Kristian Thygesen (DE)(study group founder)Past–Chair
We welcome the application of candidates who:• Are ACCA paying members (Ivory, Silver or Gold) - JOIN ACCA • Have contributed substantially to the field of biomarkers with multiple original scientific papers published in top journals• Have a documented interest in education issues in the field• Provide complimentary expertise to the current members
The application should be sent electronically via eform and contain the following:1. A motivation letter describing the applicant’s expertise in the field of biomarkers, and what the applicant thinks she/he would contribute to the group (maximum 1 page).2. An up-to-date CV that provides information on the applicant’s education, positions held, grants, educational experience and professional activities.3. An up-to-date list of published peer-reviewed original and review articles.4. Copies of the applicant’s five most relevant articles in the field of biomarkers.
In order to increase the representation of female scientists in the ESC ACCA study groups, a female candidate would be preferred in case of identical qualification as to a male candidate.
Deadline for the application is 20 May 2018
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved